Cytosorbents Corporation (CTSO)
Nasdaq • CTSO • US23283X3052
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 4.8% of free float sold short, 1.9 days to cover, cost to borrow 1.44%. Sign up for live short interest data.
Market Cap
16.6m USD | # 10523 in US
Volume
35.54k shares | 194.2k USD
Shares Outstanding
3.15m
Free Float Shares
88.22% | 2.78m
